1. Home
  2. TWST vs EFC Comparison

TWST vs EFC Comparison

Compare TWST & EFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Twist Bioscience Corporation

TWST

Twist Bioscience Corporation

HOLD

Current Price

$29.62

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

EFC

Ellington Financial Inc.

HOLD

Current Price

$13.62

Market Cap

1.5B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TWST
EFC
Founded
2013
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
2018
2010

Fundamental Metrics

Financial Performance
Metric
TWST
EFC
Price
$29.62
$13.62
Analyst Decision
Buy
Strong Buy
Analyst Count
9
7
Target Price
$46.33
$14.46
AVG Volume (30 Days)
1.9M
1.5M
Earning Date
11-14-2025
11-05-2025
Dividend Yield
N/A
11.46%
EPS Growth
N/A
1.22
EPS
N/A
1.33
Revenue
$376,572,000.00
$329,815,000.00
Revenue This Year
$17.89
N/A
Revenue Next Year
$16.81
$8.81
P/E Ratio
N/A
$10.22
Revenue Growth
20.32
13.84
52 Week Low
$23.30
$11.12
52 Week High
$55.33
$14.40

Technical Indicators

Market Signals
Indicator
TWST
EFC
Relative Strength Index (RSI) 49.37 49.44
Support Level $25.67 $13.30
Resistance Level $31.80 $14.04
Average True Range (ATR) 1.96 0.20
MACD 0.25 -0.02
Stochastic Oscillator 71.98 42.57

Price Performance

Historical Comparison
TWST
EFC

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.

About EFC Ellington Financial Inc.

Ellington Financial Inc is a specialty finance company. Its primary investment objective is to generate attractive, risk-adjusted total returns for its shareholders by making investments. The company has two reportable segments; The Investment Portfolio Segment is focused on investing in a diverse array of financial assets, including residential and commercial mortgage loans, residential mortgage-backed securities, non-mortgage- and mortgage-related derivatives, debt and equity investments in loan origination companies, and other strategic investments, and The Longbridge Segment is focused on the origination and servicing of reverse mortgage loans. it acquires reverse mortgage loans both through its origination activities and through secondary market purchases.

Share on Social Networks: